Elias Traboulsi, MD, MEd

• Editor-in-Chief, Ophthalmic Genetics
• Executive Editor, American Journal of Ophthalmology
• Author, Textbook of Genetic Diseases of the Eye, Oxford University Press
• Director, Vision First, a privately funded program for vision screening and detection of amblyopia and other eye diseases of children in the Cleveland Public Schools. More than 20,000 children examined to date.
• Past President, Current Executive Vice-President, International Society for Genetic Eye Diseases and Retinoblastoma

• Alpha Omega Alpha Honor Medical Society Member, 1981
• Fellowship Award, Children’s National Eye Care Foundation, 1989-1990
• Marshall M. Parks Fellowship Award, Costenbader Society, 1989-1990
• L. Harrell Pierce Wilmer Resident Teaching Award, 1995
• First Camille Matta Visiting Professor and Lecturer, American University of Beirut Medical Center, 1995
• Honor Award, American Academy of Ophthalmology, 1995
• Recognition Award for Outstanding Dedication and Leadership, Johns Hopkins Bayview Medical Center, 1990-1997
• Clinician Scientist Award, Cleveland Clinic Eye Institute, 1998
• Faculty Recognition Award, Joint Commission for Allied Health Personnel in Ophthalmology, 1998 
• Robb-Petersen Lectureship in pediatric ophthalmology, Boston Children’s Hospital, “The Clinical and Molecular Genetic Aspects of Ocular Malformations,” 1999
• John-Pratt Johnson Lectureship in pediatric ophthalmology, Canadian Orthoptic Society, “The Genetics of Strabismus,” 2000
• Inaugural Martha Leffler Lincoln Lectureship in pediatric ophthalmology, The Wilmer Eye Institute of Johns Hopkins University School of Medicine, “Lid Fissure Configuration and Astigmatism in Children,” 2001
• Honor Award, American Association for Pediatric Ophthalmology and Strabismus, 2002
• Physician-of-the-Year Award, Cleveland Clinic International Center, 2002
• Honorary Member, “Società Italiana Oftalmologia Genetica” (SIOG) (Italian Society of Genetic Ophthalmology), 2004
• Honorary Member, Columbian Pediatric Ophthalmology Group, 2004
• Georgia Knights Templar Educational Trust Lecturer, Emory Eye Center, Emory University, 2004
• Elected to the American Ophthalmological Society, 2004. Thesis: \"Congenital Abnormalities of Cranial Nerve Development: Overview, Molecular Mechanisms and Further Evidence of Heterogeneity and Complexity of Syndromes with Congenital Limitation of Eye Movements”
• Senior Honor Award, American Academy of Ophthalmology, 2005
• Ollendorff Lectureship, The Edward S. Harkness Eye Institute, Columbia University, New York, 2006
• Johnson Lectureship, Seattle Children’s Hospital, University of Washington, 2006
• William B. Scott Lectureship, Department of Ophthalmology, University of Iowa, 2007
• 35th Victor G. Simpson Lectureship, Department of Ophthalmology, Washington Hospital Center and Georgetown University Hospital, Washington, D.C., 2007
• Teacher of the Year, Cole Eye Institute, 2007
• Best Doctors in America, Several Years in a Row
• Funding from the National Eye Institute, Research to Prevent Blindness, Foundation Fighting Blindness, and other organizations as well as private funding

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2026-03-24, Dr. Traboulsi has reported no financial relationship with industry that is applicable to this listing.

In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.